| MYBL2 (B-Myb): a central regulator of cell proliferation, cell survival and differentiation involved in tumorigenesis J Musa, MM Aynaud, O Mirabeau, O Delattre, TGP Grünewald Cell death & disease 8 (6), e2895-e2895, 2017 | 253 | 2017 |
| Sarcoma treatment in the era of molecular medicine TGP Grünewald, M Alonso, S Avnet, A Banito, S Burdach, F Cidre‐Aranaz, ... EMBO molecular medicine 12 (11), e11131, 2020 | 189 | 2020 |
| Eukaryotic initiation factor 4E-binding protein 1 (4E-BP1): a master regulator of mRNA translation involved in tumorigenesis J Musa, MF Orth, M Dallmayer, M Baldauf, C Pardo, B Rotblat, T Kirchner, ... Oncogene 35 (36), 4675-4688, 2016 | 158 | 2016 |
| Robust diagnosis of Ewing sarcoma by immunohistochemical detection of super-enhancer-driven EWSR1-ETS targets MC Baldauf, MF Orth, M Dallmayer, A Marchetto, JS Gerke, RA Rubio, ... Oncotarget 9 (2), 1587, 2018 | 80 | 2018 |
| PRC1: linking cytokinesis, chromosomal instability, and cancer evolution J Li, M Dallmayer, T Kirchner, J Musa, TGP Grünewald Trends in cancer 4 (1), 59-73, 2018 | 73 | 2018 |
| Cooperation of cancer drivers with regulatory germline variants shapes clinical outcomes J Musa, F Cidre-Aranaz, MM Aynaud, MF Orth, MML Knott, O Mirabeau, ... Nature communications 10 (1), 4128, 2019 | 58 | 2019 |
| Oncogenic hijacking of a developmental transcription factor evokes vulnerability toward oxidative stress in Ewing sarcoma A Marchetto, S Ohmura, MF Orth, MML Knott, MV Colombo, C Arrigoni, ... Nature communications 11 (1), 2423, 2020 | 40 | 2020 |
| Gene expression and immunohistochemical analyses identify SOX2 as major risk factor for overall survival and relapse in Ewing sarcoma patients G Sannino, A Marchetto, A Ranft, S Jabar, C Zacherl, R Alba-Rubio, ... EBioMedicine 47, 156-162, 2019 | 28 | 2019 |
| Translational evidence for RRM2 as a prognostic biomarker and therapeutic target in Ewing sarcoma S Ohmura, A Marchetto, MF Orth, J Li, S Jabar, A Ranft, E Vinca, ... Molecular Cancer 20, 1-7, 2021 | 26 | 2021 |
| Targeting the CALCB/RAMP1 axis inhibits growth of Ewing sarcoma M Dallmayer, J Li, S Ohmura, R Alba Rubio, MC Baldauf, TLB Hölting, ... Cell death & disease 10 (2), 116, 2019 | 25 | 2019 |
| Systematic identification of cancer-specific MHC-binding peptides with RAVEN MC Baldauf, JS Gerke, A Kirschner, F Blaeschke, M Effenberger, ... Oncoimmunology 7 (9), e1481558, 2018 | 22 | 2018 |
| High specificity of BCL11B and GLG1 for EWSR1-FLI1 and EWSR1-ERG positive Ewing sarcoma MF Orth, TLB Hölting, M Dallmayer, FS Wehweck, T Paul, J Musa, ... Cancers 12 (3), 644, 2020 | 21 | 2020 |
| Hepatitis B virus large surface protein is priming for hepatocellular carcinoma development via induction of cytokinesis failure J Musa, J Li, TGP Grünewald The Journal of pathology 247 (1), 6-8, 2019 | 20 | 2019 |
| Integrative clinical transcriptome analysis reveals TMPRSS2‐ERG dependency of prognostic biomarkers in prostate adenocarcinoma JS Gerke, MF Orth, Y Tolkach, L Romero‐Pérez, FS Wehweck, S Stein, ... International journal of cancer 146 (7), 2036-2046, 2020 | 12 | 2020 |
| Functional genomics identifies AMPD2 as a new prognostic marker for undifferentiated pleomorphic sarcoma MF Orth, JS Gerke, T Knösel, A Altendorf‐Hofmann, J Musa, ... International journal of cancer 144 (4), 859-867, 2019 | 12 | 2019 |
| MYBL2 (B-Myb): a central regulator of cell proliferation, cell survival and differentiation involved in tumorigenesis. Cell Death Dis 8: e2895 J Musa, MM Aynaud, O Mirabeau, O Delattre, TG Grunewald | 12 | 2017 |
| Eukaryotic translation initiation factor 4E binding protein 1 (EIF4EBP1) expression in glioblastoma is driven by ETS1- and MYBL2-dependent transcriptional … L Hauffe, D Picard, J Musa, M Remke, TGP Grünewald, B Rotblat, ... Cell Death Discovery 8 (1), 91, 2022 | 11 | 2022 |
| Therapeutic targeting of the PLK1-PRC1-axis triggers cell death in genomically silent childhood cancer J Li, S Ohmura, A Marchetto, MF Orth, R Imle, M Dallmayer, J Musa, ... Nature Communications 12 (1), 5356, 2021 | 10 | 2021 |
| Outcome after surgical resection of multiple recurrent retroperitoneal soft tissue sarcoma F Willis, J Musa, S Schimmack, U Hinz, G Mechtersheimer, M Uhl, ... European Journal of Surgical Oncology 47 (8), 2189-2200, 2021 | 9 | 2021 |
| Proliferation assessment by trypan blue exclusion in ewing sarcoma CM Funk, J Musa Ewing Sarcoma: Methods and Protocols, 151-158, 2021 | 9 | 2021 |
Thomas G. P. GrünewaldHopp-Children´s Cancer Center Heidelberg (KiTZ)Bestätigte E-Mail-Adresse bei kitz-heidelberg.de
